Precision genome editing
Light Horse applies precision genome editing to small-molecule drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
Light Horse applies precision genome editing to small-molecule drug discovery, targeting root causes of disabling and life-threatening diseases.
Its platform identifies chemically accessible functional domains within targets involved in disease biology. Its high-throughput platform systematically examines complex signaling pathways to identify sites of vulnerability.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Light Horse applies precision genome editing to small-molecule drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
Its high-throughput discovery platform systematically interrogates complex signaling pathways to uncover sites of vulnerability.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 19, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 10, 2026, September 13, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026 and September 27, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.